MultiCell Technologies Inc (MCET)

[SkipDawg]

HERE IS A PARAGRAPH TAKEN FROM AMARIN AND MULTICELL PRESS RELEASE.....SOUNDS GOOD TO ME.

"Multicell intends to proceed with the anticipated pivotal Phase IIb/III trial of MCT-125 using the data generated by Amarin for LAX-202 following discussions with the FDA. If MCT-125 is approved for the treatment of fatigue in MS patients by the FDA and other such regulatory agencies, and is successfully commercialized, Multicell estimates MCT-125 could generate up to $3 billion in cumulative worldwide sales during the time MCT-125 is under patent protection."

http://www.sec.gov/Archives/edgar/data/897448/000095016206000002/ex99_1.htm